Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-α1, interferon-β1, and other 9p21 markers in human malignant cell lines

Cancer Genetics and Cytogenetics

Volumn 86, Issue 1, 1996, Pages 22-28

  Zhang, Hongyang ^a   Chen, Zhi Hao ^a   Savarese, Todd M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' METHYLTHIOADENOSINE PHOSPHORYLASE; ALPHA1 INTERFERON; BETA1 INTERFERON; TUMOR MARKER; 5'-METHYLTHIOADENOSINE PHOSPHORYLASE; ALPHA INTERFERON; BETA INTERFERON; CARRIER PROTEIN; PROTEIN P16INK4A; PURINE NUCLEOSIDE PHOSPHORYLASE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CENTROMERE; CHROMOSOME 9P; CHROMOSOME SATELLITE; DIAGNOSIS; GENE DELETION; GENE LOCUS; HUMAN; HUMAN CELL; INCIDENCE; PREDICTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; CELL CULTURE; CHROMOSOME 9; GENETIC MARKER; GENETICS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE DELETION; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PURINE-NUCLEOSIDE PHOSPHORYLASE; RNA-DIRECTED DNA POLYMERASE; TUMOR CELLS, CULTURED;

EID: 0029670305     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(95)00157-3     Document Type: Article

References (36)

1. Diaz MO, Ziemin S, Le Beau MM, Pitha P, Smith SD, Chilcote RR, Rowley JD (1988): Homozygous deletion of the α- and β-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci USA 85:5259-5263.
2. Diaz MO, Rubin CM, Harden A, Ziemin S, Larson RA, Le Beau MM, Rowley JD (1990): Deletions of interferon genes in acute lymphoblastic leukemia. N Engl J Med 332:77-82.
3. Miyakoshi J, Dobler KD, Allalunis-Turner J, McKean JDS, Petruk K, Allen PBR, Aronyk KN, Weir B, Huyser-Wierenga D, Fulton D, Urtasun RG, Day III RS (1990): Absence of IFNA and IFNB genes from human malignant cell lines and lack of correlation with cellular sensitivity to interferons. Cancer Res 50:278-283.
4. Olopade O, Bohlander SK, Pomykala H, Maltepe E, Melle EV, Le Beau MM, Diaz MO (1992): Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia. Genomics 14:437-443.
5. Olopade OI, Jenkins RB, Ransom DT, Malik K, Pomykala H, Nobori T, Cowan JM, Rowley JD, Diaz MO (1992): Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 52:2523-2529.
6. James CD, He J, Collins VP, Allalunis-Turner MJ, Day III RS (1993): Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group. Cancer Res 53:3674-3676.
7. Fountain JW, Karayiorgou M, Ernstoff MS, Kirkwood JM, Vlock DR, Titus-Ermstoff L, Bouchard B, Vijayasaradhi S, Houghton AN, Lahti J, Kidd VJ, Housman DE, Dracopoli NC (1992): Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci USA 98:10557-10561.
8. Olopade OI, Buchhagen DL, Malik K, Sherman J, Nobori T, Bader S, Nau MM, Gazdar AF, Minna JD, Diaz MO (1993): Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res 53:2410-2415.
9. Mead LJ, Gillespie MT, Irving LB, Campbell LJ (1994): Homozygous and hemizygous deletions of 9p centromeric to the interferon genes in lung cancer. Cancer Res 54:2307-2309.
10. Cheng JO, Jhanwar SC, Lu YY, Testa JR (1993): Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas. Cancer Res 53:4761-4673.
11. Cairns P, Tokino K, Eby Y, Sidransky D (1994): Homozygous deletions of 9p21 in primary human bladder detected by comparative multiplex polymerase chain reaction. Cancer Res 54:1422-1424.
12. Stadler WM, Sherman J, Bohlander SK, Roulston D, Dreyling M, Rukstalis D, Olopade OI (1994): Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Cancer Res 54:2060-2063.
13. van der Riet P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W, Sidransky D (1994): Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 54:1156-1158.
14. Carrera CJ, Eddy RL, Shows TB, Carson DA (1994): Assignment of the gene for methylthioadenosine phosphorylase to human chromosome 9 by mouse-human somatic cell hybridization. Proc Natl Acad Sci USA 81:2665-2668.
15. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE, Skolnik MH (1994): A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
16. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994): Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756.
17. Serrano M, Hannon GJ, Beach D (1993): A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707.
18. PSK-13/cdk4) for mammalian D type G1 cyclins. Cell 71:323-334.
19. 1 cyclins. Cell 73:1059-1065.
20. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D (1994): Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265:415-417.
21. Ogawa S, Hirano N, Sato N, Takahashi T, Hangaishi A, Tanaka K, Kurokawa M, Tanaka T, Mitani K, Yazaki Y, Hirai H (1994): Homozygous loss of the cyclin-dependent kinase 4 inhibitor (p16) gene in human leukemias. Blood 84:2431-2435.
22. Caldas C, Hahn SA, daCosta LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE (1994): Frequent somatic mutations and homozygous deletions of the p16 (MTS-1) gene in pancreatic adenocarcinoma. Nature Genetics 8:27-32.
23. Schmidt EE, Ichimura K, Reifenberger G, Collins VP (1994): CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 54:6321-6324.
24. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Wilson JKV, Kinzler KW, Vogelstein B (1994): Deletion of p16 and p15 genes in brain tumors. Cancer Res 54:6353-6358.
25. Giani C, Finocchiaor G (1994): Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res 54:6338-6339.
26. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y (1994): Frequent somatic mutation of the MTS-1 /CDK4I (multiple tumor suppressor/cyclin dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Can Res 54:3396-3397.
27. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9:3375-3378.
28. Weaver-Feldhaus J, Gruis NA, Neuhausen S, LePaslier D, Stockert E, Skolnick MH, Kamb A (1994): Localization of a putative tumor suppressor gene using homozygous deletions in melanomas. Proc Natl Acad Sci USA 91:7563-7567.
29. Strauss WM (1987): Preparation of genomic DNA from mammalian tissue. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Smith JA, Seidman JG, Struhl K (eds.). Current Protocols in Molecular Biology. Wiley-Interscience, New York, pp. 2.2.1-2.2.3.
30. Savarese TM, Harrington S, Nakamura C, Chen ZH, Kumar P, Mikkilineni A, Abushanab E, Chu SH, Parks RE Jr (1990): 5′-Deoxy-5′-methylthioadenosine phosphorylase-V. Acycloadenosine derivatives as inhibitors of the enzyme. Biochem Pharmacol 40:2465-2472.
31. Bradford M (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
32. Kwiatkowski DJ, Armour J, Bale AE, Fountain JW, Goudie D, Haines JL, Knowles MA, Pilz A, Slaugenhaupt S, Povey S (1993): Report on the second international workshop on human chromosome 9. Cytogenet Cell Genet 64:94-103.
33. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G, Lathrop MA (1992): A second-generation linkage map of the human genome. Nature 359:794-801.
34. Murty VVVS, Bouchard B, Mathew S, Vijayasaradhi S, Houghton AN (1992): Assignment of the human TYRP (brown) locus to chromosome region 9p23 by nonradioactive in situ hybridization. Genomics 13:227-229.
35. Kamatani N, Nelson-Rees WA, Carson DA (1981): Selective killing of human malignant cell lines deficient in methylthio-adenosine phosphorylase, a purine metabolic enzyme. Proc Natl Acad Sci USA 78:1219-1223.
36. He J, Allen JR, Collins VP, Allalunis-Turner M, Godbout R, Day RS III, James CD (1994): CDK amplification is an alternative mechanism to p16 homozygous deletion in glioma cell lines. Cancer Res 54:5804-5807.